Dimokritos S.A.

What Dimokritos S.A. does

Dimokritos S.A. is a Greek private diagnostic laboratory group founded in 2008, operating a regional network of clinical laboratories and diagnostic imaging centers across Northern Greece (Thrace, Eastern Macedonia, and Thessaly). The group runs 13+ facilities comprising six radiology centers, seven microbiology laboratories, and two blood collection points, anchored in Orestiada and extending to Alexandroupoli, Didymoteicho, Xanthi, Komotini, Serres, Agia Larissas, Dikaia, and Metaxades. It is the only ESYD-accredited (ISO 15189) medical laboratory in Thrace and the largest by certified test volume in the Eastern Macedonia and Thrace region, with results accepted across Europe without re-testing.

The service portfolio spans the full diagnostic pathway: imaging (MRI with Philips Ambient Experience, CT, X-ray, ultrasound/Triplex, digital and 3D tomosynthesis mammography, bone densitometry, orthopantomography, cardiac MRI), clinical laboratory testing (hematology, biochemistry, immunology, microbiology cultures, molecular biology, prenatal screening), preventive check-up packages, and ambulance patient transport. Technology is delivered through physical facilities supported by in-house digital platforms including the WebLis laboratory information system (multilingual, ISO 15189-accredited workflow) and the e-test.app patient platform, plus dedicated patient (patient.dimokritos.org) and physician (my.dimokritos.org) portals. Certifications include ISO 9001:2015 (TUV AUSTRIA HELLAS), ISO 15189:2012 renewed to ISO 15189:2022 (ESYD), and ISO 50001:2018.

The business model is professional-services fee-for-service revenue from a direct-to-consumer and physician-referred patient base, with payment sourced from Greece's National Health System (EOPYY) for insured patients plus private/out-of-pocket payments for uninsured and supplementary services. Premium offerings such as the VIP whole-body MRI screening target self-pay preventive-medicine consumers. Demand generation relies on physician referrals, the group's website and health-education content, national public screening programmes (e.g., 'Fofi Gennimata' mammography), and community/corporate social responsibility activities, rather than performance marketing. The group is led by President Nikos Pantazis, a radiologist, and operates as an unlisted Ανώνυμη Εταιρεία (S.A.) under Greek law.

Name

Dimokritos S.A.

Legal name

ΔΗΜΟΚΡΙΤΟΣ Πρότυπο Ιδιωτικό Διαγνωστικό Εργαστήριο Α.Ε.

Website

https://dimokritos.org

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

Dimokritos S.A. is a Greek private diagnostic laboratory group operating 13+ imaging and microbiology centers across Northern Greece (Thrace, Eastern Macedonia, Thessaly). It serves individual patients and referring physicians with MRI, CT, laboratory, and preventive screening services, holding the only ESYD ISO 15189 accreditation in Thrace.

Ownership category

akta.pro rank

Product category

Medical Diagnostic Laboratory and Imaging Services

NAICS

Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151), Diagnostic Imaging Centers (621512)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)

akta.pro secondary industry

Urinalysis & Routine Screening Diagnostics (HLAHAAAG)

Keywords

• Medical diagnostic services
• Clinical laboratory testing
• Diagnostic imaging services
• Preventive health screening
• Radiology and imaging

Headquarters

HQ city

Orestiada

HQ country

Greece

HQ region

Europe

Offices13 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Diagnostic Laboratory Services: Revenue is generated from a comprehensive range of laboratory and imaging diagnostic services billed per examination or test. Services include blood tests (hematology, biochemistry, immunology, molecular biology), microbiological cultures, imaging (MRI, CT, X-ray, ultrasound, mammography, bone density), and preventive health check-up packages. The group operates on a direct-to-consumer model with National Health System (ΕΟΠΥΥ) coverage for insured patients, with additional out-of-pocket payments for uninsured or supplementary services. No specific pricing is publicly disclosed on the website.
2. Ambulance/Patient Transport Services: The group operates ambulance transport services for patient transportation to and from diagnostic facilities, providing an additional service revenue stream.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Dimokritos S.A. is a private diagnostic medicine group that provides clinical laboratory testing and diagnostic imaging services through a network of owned diagnostic centers in Northern Greece (Komotini, Alexandroupoli, Xanthi, Kavala, Drama) plus remote radiology and microbiology networks. Its offering spans hematology, biochemistry, immunology, microbiology, molecular biology and cytology laboratory tests, alongside MRI, CT, X-ray, ultrasound, digital mammography with 3D tomosynthesis, DEXA and panoramic dental imaging, with online results delivery, home sample collection and ambulance transport.

Product overview

Dimokritos S.A. is a diagnostic laboratory group offering a comprehensive portfolio of laboratory and imaging services across northern Greece. The core offering includes clinical laboratory testing (hematology, biochemistry, microbiology, molecular biology, immunology) and diagnostic imaging (MRI, CT, X-ray, ultrasound, mammography). Premium services include VIP Screening with whole-body MRI for preventive health assessments. Services are delivered through a network of radiology centers, microbiology laboratories, and blood banks across Orestiada, Alexandroupoli, Xanthi, Komotini, Serres, Agia Larisa, and blood banks in Dikea and Metaxades. The group also provides ambulance transport services and operates digital platforms including WebLis LIS and e-test.app.

Differentiator

Problem solved

Functional benefit

Brands

• WebLis: Laboratory information management system portal for accessing test results
• e-test.app
• VIP Screening MRI

Products and services

• Diagnostic Imaging Services (MRI, CT, X-ray, Ultrasound, Mammography, DEXA) Diagnostic imaging examinations (MRI with Philips Ambient Experience, multi-slice CT, X-ray, ultrasound, digital mammography with 3D tomosynthesis, DEXA bone densitometry, panoramic dental) performed for outpatients and referred patients across the Dimokritos branch network, with reports issued by named radiologists such as Dr. Pantazis and Dr. Terzenidis.
• Clinical Laboratory Testing (Hematology, Biochemistry, Immunology, Microbiology, Molecular Biology, Cytology) Comprehensive clinical laboratory analysis covering hematology, biochemistry, immunology, microbiology, molecular biology and cytology for outpatients, hospital referrals and corporate clients. Results delivered digitally via WebLis and e-test.app portals; tests include PCR infectious-disease panels, genetic/molecular oncology assays, cytology and routine biochemistry/hematology panels.
• Check-up / Preventive Health Screening Packages Pre-packaged check-up and preventive screening programs (general annual check-up, targeted panels) combining laboratory testing and imaging studies and packaged for individuals and corporate buyers.
• VIP Whole-Body MRI Screening Program Premium executive / sports whole-body MRI screening service marketed to corporate clients, sports clubs and self-pay patients as a comprehensive preventive imaging package performed on the group's 1.5T MRI scanner.
• Ambulance / Patient Transport Service Ambulance and patient transport service for moving patients between home, care facilities and Dimokritos diagnostic centers, particularly used by elderly, mobility-impaired or remote-region patients.

Quantifiable outcome

• ISO 15189:2022 accredited laboratory results accepted across Europe without re-testing
• +2 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Interreg Greece-Bulgaria ProgrammeminorOthersDimokritos participated in the Interreg Greece-Bulgaria cross-border cooperation programme, which provides health services in hard-to-reach areas. The programme aimed to improve access to healthcare services for populations in cross-border regions, reflecting Dimokritos' mission to serve remote border communities.

Scale indicators4 records

Recent moves14 records

Expansion highlights6 records

Broad incumbents

• IASO Group: Major Greek private healthcare group operating maternity and general hospitals with diagnostic laboratory and imaging services. Comparable for diagnostic capabilities, though broader in scope including inpatient care.
• Iatriko Group: Greek private healthcare group offering diagnostic and clinical services. Comparable for diagnostic laboratory and imaging capabilities, though with a broader portfolio including general healthcare services.
• Hygeia Hospital: Major Greek private hospital group offering comprehensive diagnostic laboratory and imaging services. Comparable for advanced diagnostic capabilities, though as part of broader hospital operations.
• Mitera Hospital: Greek private hospital within the HYGEIA group with diagnostic laboratory and imaging services. Comparable for multi-modality diagnostic offerings integrated with broader hospital operations.

Regional players

• Geniki Kliniki Thessalonikis: Regional Greek private general clinic in Thessaloniki offering diagnostic laboratory and imaging services. Comparable as a Northern Greek healthcare provider with diagnostic capabilities, though primarily serving a different regional market.

Direct peers

• Bioiatriki: One of Greece's largest private diagnostic laboratory and imaging networks, operating nationwide with a similar multi-modality service portfolio. Directly comparable as a multi-site clinical diagnostics provider serving both insured and private-pay patients.
• Euromedica: Greek private diagnostic and healthcare services group with nationwide presence. Comparable as a multi-site diagnostic laboratory and imaging services provider serving insured and private-pay patients across multiple regions.
• Affidea Greece: Greek operations of a European diagnostic imaging chain. Directly comparable as a multi-site imaging services provider with advanced equipment (MRI, CT) and focus on diagnostic excellence.
• Diagnostiki Athinon: Greek diagnostic laboratory network focused on clinical lab services. Directly comparable as a Greek diagnostic lab provider with multi-location presence serving insured and private-pay patients.
• Synlab Greece: Greek operations of European medical diagnostics provider. Comparable as a multi-site clinical diagnostic laboratory services provider with broad test menu, ISO accreditation, and B2B/B2C physician referral channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights3 records

Customer concentration

• LinkedInlinkedin.com/company/dimokritos

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries17 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dimokritos S.A.